Infection

Global Veterinary Infectious Diseases Diagnostics Market Analysis 2020-2025, Featuring Key Players Abaxis, Zoetis Services LLC and Agrolabo S.p.A

Friday, May 22, 2020 - 10:45pm

DUBLIN, May 22, 2020 /PRNewswire/ -- The "Veterinary Infectious Diseases Diagnostics Market - Forecasts from 2020 to 2025" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, May 22, 2020 /PRNewswire/ -- The "Veterinary Infectious Diseases Diagnostics Market - Forecasts from 2020 to 2025" report has been added to ResearchAndMarkets.com's offering.
  • The veterinary infectious diseases diagnostics market is projected to grow at a CAGR of 7.98% to reach US$5.369 billion by 2025.
  • This is driving the requirement of diagnostics services and veterinary services for these animals to prevent the risk of getting seriously ill by infections.
  • This report segments the Veterinary Infectious Diseases Diagnostics Market as follows:

Impact of COVID-19 on the Worldwide Anti-Infective Drugs Industry to 2030 - Benchmark Performance Against Key Competitors - ResearchAndMarkets.com

Friday, May 22, 2020 - 4:32pm

The global anti-infective drugs market is expected to grow from $106.5 billion in 2019 to $139.3 billion in 2020 at a compound annual growth rate (CAGR) of 30.8%.

Key Points: 
  • The global anti-infective drugs market is expected to grow from $106.5 billion in 2019 to $139.3 billion in 2020 at a compound annual growth rate (CAGR) of 30.8%.
  • The significant growth is mainly due to the COVID-19 outbreak and the huge demand for anti-viral and antibiotic drugs.
  • North America was the largest region in the global anti-infective drugs market, accounting for 50% of the market in 2019.
  • The anti-infective drugs market consists of sales of anti-infective drugs and related services by entities (organizations, sole traders and partnerships) that produce anti-infective drugs to treat microbial infections.

Global Antibiotics Market (2020 to 2027) - COVID-19 Impact and Global Analysis by Drug Class, Action Mechanism and Geography - ResearchAndMarkets.com

Thursday, May 21, 2020 - 11:37am

The "Antibiotics Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Drug Class; Action Mechanism, and Geography" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Antibiotics Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Drug Class; Action Mechanism, and Geography" report has been added to ResearchAndMarkets.com's offering.
  • The growing prevalence of bacterial infection is one of the major factors increasing the demand for antibiotics globally.
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the antibiotics market.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

Global Veterinary Infectious Diseases Diagnostics Market: New Technology Launches by Key Market Players - ResearchAndMarkets.com

Thursday, May 21, 2020 - 10:55am

The "Veterinary Infectious Diseases Diagnostics Market - Forecasts from 2020 to 2025" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Veterinary Infectious Diseases Diagnostics Market - Forecasts from 2020 to 2025" report has been added to ResearchAndMarkets.com's offering.
  • The veterinary infectious diseases diagnostics market is projected to grow at a CAGR of 7.98% to reach US$5.369 billion by 2025.
  • Better, advanced and diverse varieties of veterinary infectious diseases diagnostics with enhanced features that are able to effectively aid in the proper and efficient diagnosis and detection of the diseases are being launched.
  • This report segments the Veterinary Infectious Diseases Diagnostics Market as follows:

China's Infection Control Market Report 2020 with Forecasts to 2025 - ResearchAndMarkets.com

Thursday, May 21, 2020 - 10:41am

The "China Infection Control Market - Forecasts from 2020 to 2025" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "China Infection Control Market - Forecasts from 2020 to 2025" report has been added to ResearchAndMarkets.com's offering.
  • The China infection control market is projected to grow at a CAGR of 11.37% during the forecast period.
  • Therefore, increased investment in infection prevention products and solutions is expected which in turn is projected to fuel the growth of infection control market growth.
  • The "China Infection Control Market" report segments the industry as follows:

Press release - Protection of workers from biological agents: how to classify COVID-19

Thursday, May 21, 2020 - 12:09am

The SARS and MERS viruses are examples of risk group 3 viruses.

Key Points: 
  • The SARS and MERS viruses are examples of risk group 3 viruses.
  • Ebola is in risk group 4.EU directives protect workers against the risks of exposure to biological agents (bacteria, viruses and other micro-organisms) at work.
  • Depending on their level of danger, they are classified in risk groups on an increasing scale from 1 to 4.
  • They are classified into four risk groups according to their level of risk of infection:

    Follow the Committee on Employment and Social Affairs on twitter

    Sign up to our news subscription services

Testing for drug-related infectious diseases — a crucial step towards meeting international health goals

Thursday, May 21, 2020 - 12:09am

Testing for drug-related infectious diseases among people who inject drugs (PWID) is crucial if international health targets are to be met.

Key Points: 
  • Testing for drug-related infectious diseases among people who inject drugs (PWID) is crucial if international health targets are to be met.
  • This is among the conclusions of a new EMCDDA report out today: Drug-related infectious diseases in Europe.
  • The update, from the agencys drug-related infectious disease network, stresses that early diagnosis through testing, and improving links to treatment and care, are crucial steps towards reaching global health goals.
  • Launched during European Testing Week (1522 May), the report offers an overview of drug-related infectious diseases among PWID in Europe, including the prevalence and incidence of HIV and viral hepatitis.

Press release - Protection of workers from biological agents: how to classify COVID-19

Wednesday, May 20, 2020 - 8:01pm

The SARS and MERS viruses are examples of risk group 3 viruses.

Key Points: 
  • The SARS and MERS viruses are examples of risk group 3 viruses.
  • Ebola is in risk group 4.EU directives protect workers against the risks of exposure to biological agents (bacteria, viruses and other micro-organisms) at work.
  • Depending on their level of danger, they are classified in risk groups on an increasing scale from 1 to 4.
  • They are classified into four risk groups according to their level of risk of infection:

    Follow the Committee on Employment and Social Affairs on twitter

    Sign up to our news subscription services

Functional Foods and Drinks Market to Reach a Revised Size of $229 Billion by 2027 - Focus Shifts Towards Boosting the Immune System Amid COVID-19 - ResearchAndMarkets.com

Wednesday, May 20, 2020 - 4:57pm

There is a massive opportunity in a healthcare crisis for Functional Foods and Drinks, as all focus shifts towards boosting the immunity in fighting the disease in the absence of known cure and treatment.

Key Points: 
  • There is a massive opportunity in a healthcare crisis for Functional Foods and Drinks, as all focus shifts towards boosting the immunity in fighting the disease in the absence of known cure and treatment.
  • The global market is projected to reach a revised size of US$229.1 billion by 2027.
  • While rising focus on healthy diets with disease-preventing, longevity-increasing, and health-promoting functional nutrients has always been a key growth driver, the current pandemic has catalyzed the trend further.
  • The COVID-19 pandemic has thrown the focus on boosting the immune system to fight infectious diseases.

Babson Diagnostics Enters Collaborative Research Agreement with Dell Medical School to Study Immune Response to COVID-19

Wednesday, May 20, 2020 - 3:35pm

Babson Diagnostics (Babson), a transformative diagnostic blood testing company, announced today it has entered into a collaborative research agreement with Dell Medical School at The University of Texas at Austin (Dell Med) to study the immune response to COVID-19.

Key Points: 
  • Babson Diagnostics (Babson), a transformative diagnostic blood testing company, announced today it has entered into a collaborative research agreement with Dell Medical School at The University of Texas at Austin (Dell Med) to study the immune response to COVID-19.
  • The longitudinal research study is designed to measure the adaptive immune response to SARS-CoV-2 by following individuals over a two-year period.
  • The initial phase of the study begins with 200 COVID-19 positive individuals, including patients and health care workers from UT Health Austin, the clinical practice of Dell Med.
  • The research is designed to inform the diagnosis and treatment of COVID-19 infections as well as guide the allocation of critical medical resources.